Treace Medical CIO Sean Scanlan Has 9,814 Shares Withheld for Taxes

What Happened

• Sean F. Scanlan, Chief Innovation Officer of Treace Medical Concepts, Inc. (TMCI), had 9,814 shares disposed on 2026-08-09 as a payment to satisfy tax liability related to equity awards. The reported per-share price is $0.00 and no cash proceeds were received (this is a withholding, not an open-market sale).

Key Details

• Transaction date: 2026-08-09; Form filed: 2026-08-12.
• Transaction code: F (payment of exercise price or tax liability — here used for tax withholding).
• Shares disposed/withheld: 9,814; reported price: $0.00; reported cash proceeds: $0.
• Holdings note: Footnote F1 states the reporting person’s holdings include 463,167 restricted stock units (RSUs).
• Family transfer: Footnote F2 notes a prior transfer of 15,000 shares to the reporting person’s former spouse pursuant to a domestic relations order.
• Filing timeliness: the report lists the transaction date and the filing date; timeliness status (late/on-time) is not indicated in the summary data provided.

Context

• This was a tax-withholding event (common when RSUs vest), not an open-market sale — withheld shares are used to cover taxes and do not necessarily reflect a change in confidence in the company. For retail investors, tax withholdings are routine administrative actions rather than signals about insider sentiment.